Search by Drug Name or NDC

    NDC 72606-0023-08 Yuflyma 80 mg/.8mL Details

    Yuflyma 80 mg/.8mL

    Yuflyma is a SUBCUTANEOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by CELLTRION USA, Inc.. The primary component is ADALIMUMAB.

    Product Information

    NDC 72606-0023
    Product ID 72606-023_098ca14c-c9b4-46a4-8f4d-543840c6e1a5
    Associated GPIs
    GCN Sequence Number 085430
    GCN Sequence Number Description adalimumab-aaty AUTOINJKIT 80MG/0.8ML SUBCUT
    HIC3 S2J
    HIC3 Description ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR
    GCN 54908
    HICL Sequence Number 048955
    HICL Sequence Number Description ADALIMUMAB-AATY
    Brand/Generic Brand
    Proprietary Name Yuflyma
    Proprietary Name Suffix n/a
    Non-Proprietary Name adalimumab
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 80
    Active Ingredient Units mg/.8mL
    Substance Name ADALIMUMAB
    Labeler Name CELLTRION USA, Inc.
    Pharmaceutical Class Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA761219
    Listing Certified Through 2025-12-31

    Package

    NDC 72606-0023-08 (72606002308)

    NDC Package Code 72606-023-08
    Billing NDC 72606002308
    Package 3 SYRINGE, GLASS in 1 CARTON (72606-023-08) / .8 mL in 1 SYRINGE, GLASS
    Marketing Start Date 2023-09-29
    NDC Exclude Flag N
    Pricing Information N/A